SHBG, sex hormones, and inflammatory markers in older women.

CONTEXT In premenopausal and older women, high testosterone and estradiol (E2) and low SHBG levels are associated with insulin resistance and diabetes, conditions characterized by low-grade inflammation. OBJECTIVE The aim of the study was to examine the relationship between SHBG, total testosterone, total E2, and inflammatory markers in older women. DESIGN AND PATIENTS We conducted a retrospective cross-sectional study of 433 women at least 65 yr old from the InCHIANTI Study, Italy, who were not on hormone replacement therapy or recently hospitalized and who had complete data on SHBG, testosterone, E2, C-reactive protein (CRP), IL-6, soluble IL-6 receptor (sIL-6r), and TNF-α. Relationships between sex hormones and inflammatory markers were examined by multivariate linear regression analyses adjusted for age, body mass index, smoking, insulin, physical activity, and chronic disease. RESULTS In fully adjusted analyses, SHBG was negatively associated with CRP (P = 0.007), IL-6 (P = 0.008), and sIL-6r (P = 0.02). In addition, testosterone was positively associated with CRP (P = 0.006), IL-6 (P = 0.001), and TNF-α (P = 0.0002). The negative relationship between testosterone and sIL-6r in an age-adjusted model (P = 0.02) was no longer significant in a fully adjusted model (P = 0.12). E2 was positively associated with CRP (P = 0.002) but not with IL-6 in fully adjusted models. In a final model including E2, testosterone, and SHBG, and all the confounders previously considered, SHBG (0.23 ± 0.08; P = 0.006) and E2 (0.21 ± 0.08; P = 0.007), but not testosterone (P = 0.21), were still significantly associated with CRP. CONCLUSION In late postmenopausal women not on hormone replacement therapy, SHBG and E2 are, respectively, negative and positive, independent and significant correlates of a proinflammatory state.

[1]  W. Mbagaya Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease , 2010 .

[2]  S. Bandinelli,et al.  Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANTI study. , 2010, Rejuvenation research.

[3]  Y. Schouw,et al.  Testosterone, SHBG and cardiovascular health in postmenopausal women , 2010, International Journal of Impotence Research.

[4]  M. Jarvelin,et al.  Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes , 2009, Human molecular genetics.

[5]  S. Bandinelli,et al.  Relationship Between Higher Estradiol Levels and 9‐Year Mortality in Older Women: The Invecchiare in Chianti Study , 2009, Journal of the American Geriatrics Society.

[6]  M. Szklo,et al.  Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. , 2009, Atherosclerosis.

[7]  S. Bandinelli,et al.  Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. , 2009, Atherosclerosis.

[8]  L. Shaw,et al.  Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  D. Grobbee,et al.  Endogenous sex hormones and C‐reactive protein in healthy postmenopausal women , 2008, Journal of internal medicine.

[10]  P. Spritzer,et al.  Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. , 2008, Metabolism: clinical and experimental.

[11]  S. Bandinelli,et al.  Sex hormone binding globulin levels across the adult lifespan in women — The role of body mass index and fasting insulin , 2008, Journal of endocrinological investigation.

[12]  G. Can,et al.  Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. , 2007, Metabolism: clinical and experimental.

[13]  D. McKenzie,et al.  Endogenous androgen levels and cardiovascular risk profile in women across the adult life span , 2007, Menopause.

[14]  S. Bandinelli,et al.  Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. , 2007, American journal of physiology. Endocrinology and metabolism.

[15]  F. Orio,et al.  Cardiovascular risk in women with polycystic ovary syndrome. , 2006, Fertility and sterility.

[16]  L. Ferrucci,et al.  Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[18]  J. Manson,et al.  Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. , 2006, Annals of epidemiology.

[19]  E. Barrett-Connor,et al.  Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial. , 2006, Journal of women's health.

[20]  S. Bandinelli,et al.  Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  A. Folsom,et al.  Association of Endogenous Hormones with C-reactive Protein, Fibrinogen, and White Blood Count in Post-menopausal Women , 2005, European Journal of Epidemiology.

[22]  S. Bandinelli,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS The , 2004 .

[23]  M. Szklo,et al.  Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. , 2005, The Journal of clinical endocrinology and metabolism.

[24]  J. Manson,et al.  Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women , 2003, Circulation.

[25]  S. Kahn,et al.  BEYOND CARRIER PROTEINS Sex hormone-binding globulin is synthesized in target cells , 2002 .

[26]  C. Heinlein,et al.  The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. , 2002, Molecular endocrinology.

[27]  E. Milgrom,et al.  The postmenopausal ovary is not a major androgen-producing gland. , 2001, The Journal of clinical endocrinology and metabolism.

[28]  M. Szklo,et al.  Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. , 2001, American journal of epidemiology.

[29]  C. Longcope Endocrine Function of the Postmenopausal Ovary , 2001, Journal of the Society for Gynecologic Investigation.

[30]  Luigi Ferrucci,et al.  Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI Study , 2000, Journal of the American Geriatrics Society.

[31]  C. Mendelson,et al.  Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. , 1996, Molecular endocrinology.

[32]  J. Morley,et al.  Endocrinology in aging. , 1988, Disease-a-month : DM.